Press Releases
-
Rho’s Dr. Meagan E. Spychala Promoted to Assistant VP of Patient Engagement and Program Strategy
DURHAM - Dec 10, 2019 - For Immediate Release Rho's Dr. Meagan E. Spychala Promoted to Assistant VP of Patient Engagement and Program StrategyDrx
Dec 10, 2019
-
WCG Launches AIMS 4.1 Platform with Enhanced Endpoint Adjudication Capabilities to Facilitate Expert Review of Clinical Trial Data
PRINCETON, NJ - Dec 10, 2019 - WCG ACI Clinical, the leading specialty provider of independent endpoint adjudication and data monitoring committees for clinical trials, has launched the latest iteration of its proprietary AIMS® (Adjudication Information Management System) platform
Dec 10, 2019
-
LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium
PRINCETON, NJ - Dec 10, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that LEO Pharma has licensed its proprietary Simcyp® Population-based Simulator and joined its Consortium
Dec 10, 2019
-
PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019
NOTTINGHAM, UK - Dec 9, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces that is has won Start-Up of the Year in the 2019 Medilink East Midlands Business Awards
Dec 9, 2019
-
BioIVT to Host Drug Discovery Webinar on Gene Silencing Using siRNA In Hepatocyte Co-cultures
WESTBURY, NY - Dec 9, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is hosting a drug discovery webinar that will discuss how small interfering RNA (siRNA) molecules can be used to selectively suppress hepatic genes in an in vitro liver model and advance the development of small molecule and nucleic acid therapies
Dec 9, 2019
-
Researchers Demonstrated Utility of Droplet Digital PCR for Informing Treatment Decisions at AMP 2019 Annual Meeting and Expo
HERCULES, CA, UNITED STATES - Dec 5, 2019 - Scientists presented more than 25 abstracts demonstrating how Droplet Digital PCR (ddPCR) guides treatment decisions at the Association of Molecular Pathology (AMP) 2019 Annual Meeting and Expo in Baltimore on November 7–9
Dec 5, 2019
-
CluePoints’ Risk-Based Quality Management Software Wins Best Technological Development in Clinical Trials at SCRIP Awards 2019
KING OF PRUSSIA, PA - Dec 5, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards
Dec 5, 2019
-
NiceLabel Selected by Boehringer Ingelheim to support standardized labeling worldwide
WAUWATOSA, WI, UNITED STATES - Dec 3, 2019 - Global pharmaceutical company, Boehringer Ingelheim, has selected NiceLabel, a leading global developer of label design software and label management systems, to help it create a global standardized labeling process
Dec 3, 2019
-
Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development
NEW YORK, NY, UNITED STATES - Nov 18, 2019 - TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA's human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance
Dec 3, 2019
-
TrialScope Launches Clinical Trials Website for EMD Serono
JERSEY CITY, NJ, UNITED STATES - Dec 2, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials
Dec 2, 2019
-
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
BISHIP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth
Nov 25, 2019
-
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
PRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)
Nov 21, 2019
-
WuXi STA Forms Strategic Partnership with Impact Therapeutics
- Nov 21, 2019 - STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Impact Therapeutics, a biotech focused on innovative drug discovery and development in anti-cancer therapeutics, announce the signing of a strategic partnership agreement
Nov 21, 2019
-
Elsevier collaborates with US Food and Drug Administration to build predictive drug-induced liver injury algorithm
NEW YORK, NY - Nov 21, 2019 - Elsevier, a global information analytics business specializing in science and health, has entered into a Collaborative Research and Development Agreement (CRADA) with the National Center for Toxicological Research (NCTR) at the Food and Drug Administration (FDA)
Nov 21, 2019
-
Accumen Launches New Website to Showcase Its Expanded Range of Technologies and Services to Optimize Healthcare Performance
PHOENIX, AZ - Nov 20, 2019 - Accumen Inc., the leader in healthcare performance, today announced the launch of its new website at www
Nov 20, 2019
-
ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study
PHILADELPHIA, PA, UNITED STATES - Nov 20, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has reached a significant milestone: Global biopharmaceutical companies have relied on ERTs centralized cardiac safety solution to assess the safety of their new medical compounds in more than 10,000 clinical studies across all phases of clinical development
Nov 20, 2019
-
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
Nov 18, 2019
-
Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland
KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
Nov 18, 2019
-
Survey Findings Show Increase in Clinical Trial Results Transparency
JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
Nov 15, 2019
-
Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
PHILADELPHIA, PA, UNITED STATES - Nov 14, 2019 - Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraphs CentrePoint system
Nov 14, 2019
